The announcement of a proposed underwritten public offering of common stock by VolitionRx may have a short-term impact on its stock price. The size of the offering has not been disclosed, which adds uncertainty to the potential impact on the stock price. Investors may react positively or negatively to the news, depending on their perception of the company's growth prospects and the dilution effect of the offering.